An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid
The reporting (5)
- Tau levels fall, cognitive decline slows down with diranersen Healio · 7d ago
- Removing Amyloid Might Not Explain Why Anti-Amyloid Drugs Slow Decline Being Patient · 7d ago
- Physician Views Preview: Doctors to weigh Leqembi's new edge as tau enters the fray FirstWord Pharma · 7d ago
- Rare Human Brain Study Reveals How an Alzheimer’s Drug May Protect the Brain SciTechDaily · 7d ago
- An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid inc.com · 7d ago broke it first
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Kindergarten vaccine exemptions jump to another record high
Kindergarten vaccine exemptions reached another all-time high nationwide as the CDC released new data.
Column
A surge of August‑14 columns ties brain‑healthy habits to the future wellbeing of aging Americans
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
A breakthrough blood test promises earlier Alzheimer’s diagnosis, yet patients grapple with rising confusion and distress.
Column | 3 minutes of this activity may cut the risk of 13 cancers, study finds
A three‑minute burst of vigorous movement could slash the odds of thirteen cancers, upending the idea that only long workouts protect health.
Fact check: Trump makes numerous false and misleading claims about vaccines and autism
Recent coverage fact-checks numerous false vaccine and autism claims pushed by Donald Trump.
Why cyclospora keeps showing up in produce season after season
Utah reports nearly 50 cyclosporiasis cases, prompting local farmers to emphasize the importance of local produce.